Market Cap ₹329 Cr.
Stock P/E 124.7
P/B 4.9
Current Price ₹132.7
Book Value ₹ 26.9
Face Value 10
52W High ₹192
Dividend Yield 0%
52W Low ₹ 124
Euro India Fresh Foods Ltd is an primarily India-based snack food producer. The Company is engaged in production of chips, extruder snacks, namkeen, farali, fruit drinks and packaged consuming water. The Company elements a number of packaged snacks and fruit beverages products underneath its emblem, Euro-Fresh Khao Healthy Raho. The Company's merchandise are Euro chips; Euro Getmore; Euro Farali Wafers; Euro Namkeen, such as moong dal, peanuts, khatta meetha, combos, mamra and farali chiwda, and extruder snacks, inclusive of Euro Funfill, Ringoli, Bubbles, Puffs and Euro Wheels. In liquids, the Company supplies fruit juices below the names Euro Fresho and Euro Lemoni. Its packaged ingesting water is advertised below the name of Euro Aquaspa. The Company's merchandise are available in different flavours and in specific sort of packaging, which includes tetra packs and pet bottles. Its production facility is located at Ichchhapore, Surat, Gujarat.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 24 | 24 | 31 | 29 | 38 | 37 | 33 | 28 | 27 | 30 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 24 | 24 | 31 | 29 | 38 | 37 | 33 | 28 | 27 | 30 |
Total Expenditure | 23 | 22 | 29 | 27 | 36 | 35 | 31 | 26 | 25 | 27 |
Operating Profit | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
Provision for Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Adjusted Earnings Per Share | 0.1 | 0.1 | 0.2 | 0 | 0.1 | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 42 | 47 | 48 | 55 | 72 | 93 | 98 | 116 | 143 | 118 |
Other Income | 1 | 0 | 11 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Total Income | 43 | 48 | 59 | 56 | 73 | 93 | 99 | 117 | 143 | 118 |
Total Expenditure | 38 | 42 | 54 | 50 | 67 | 88 | 92 | 109 | 135 | 109 |
Operating Profit | 5 | 6 | 6 | 6 | 6 | 5 | 7 | 8 | 8 | 9 |
Interest | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 |
Exceptional Income / Expenses | 0 | 0 | -1 | 0 | 0 | -0 | -0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 0 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 |
Provision for Tax | 1 | 0 | -1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Profit After Tax | 0 | 0 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 2 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 2 |
Adjusted Earnings Per Share | 0 | 0 | 0.5 | 0.6 | 0.4 | 0.1 | 0.5 | 0.6 | 0.5 | 1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 23% | 15% | 21% | 0% |
Operating Profit CAGR | 0% | 17% | 6% | 0% |
PAT CAGR | 0% | 0% | -13% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -11% | 16% | 2% | NA% |
ROE Average | 2% | 2% | 2% | 2% |
ROCE Average | 5% | 5% | 5% | 5% |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 10 | 20 | 58 | 59 | 60 | 60 | 62 | 63 | 64 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 35 | 29 | 28 | 4 | 2 | 5 | 7 | 13 | 12 |
Other Non-Current Liabilities | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Total Current Liabilities | 24 | 25 | 26 | 22 | 29 | 34 | 42 | 36 | 42 |
Total Liabilities | 72 | 77 | 114 | 87 | 93 | 102 | 112 | 116 | 122 |
Fixed Assets | 30 | 30 | 30 | 31 | 30 | 33 | 35 | 33 | 33 |
Other Non-Current Assets | 1 | 1 | 3 | 4 | 4 | 3 | 3 | 2 | 2 |
Total Current Assets | 40 | 46 | 81 | 53 | 59 | 65 | 75 | 80 | 88 |
Total Assets | 72 | 77 | 114 | 87 | 93 | 102 | 112 | 116 | 122 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 0 | 37 | 0 | 0 | 0 | 1 | 0 |
Cash Flow from Operating Activities | -2 | 1 | 6 | -7 | 5 | 4 | 6 | -3 | 7 |
Cash Flow from Investing Activities | -4 | -1 | -2 | -4 | -0 | -5 | -5 | 0 | -3 |
Cash Flow from Financing Activities | 6 | 0 | 33 | -26 | -4 | 1 | -1 | 3 | -5 |
Net Cash Inflow / Outflow | 0 | -0 | 37 | -37 | 0 | -0 | 0 | -0 | -0 |
Closing Cash & Cash Equivalent | 1 | 1 | 37 | 0 | 1 | -0 | 1 | 0 | 0 |
# | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.02 | 0 | 0.55 | 0.64 | 0.36 | 0.14 | 0.53 | 0.56 | 0.49 |
CEPS(Rs) | 1.53 | 0.93 | 1.3 | 1.47 | 1.27 | 1.12 | 1.58 | 1.66 | 1.62 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 9.82 | 0 | 23.23 | 23.87 | 24.22 | 24.36 | 24.86 | 25.52 | 26 |
Core EBITDA Margin(%) | 10.51 | 11.82 | -11.91 | 8.58 | 6.41 | 5.45 | 6.55 | 6.47 | 5.46 |
EBIT Margin(%) | 8.32 | 8.18 | 6.42 | 6.32 | 4.71 | 3.2 | 4.17 | 4.33 | 3.58 |
Pre Tax Margin(%) | 1.44 | 1.04 | 1.47 | 2.93 | 1.87 | 0.83 | 1.54 | 1.86 | 1.2 |
PAT Margin (%) | 0.04 | 0.04 | 2.84 | 2.9 | 1.23 | 0.38 | 1.34 | 1.19 | 0.85 |
Cash Profit Margin (%) | 3.61 | 3.9 | 6.73 | 6.64 | 4.42 | 3 | 4 | 3.54 | 2.81 |
ROA(%) | 0.02 | 0.03 | 1.43 | 1.59 | 0.98 | 0.36 | 1.23 | 1.22 | 1.02 |
ROE(%) | 0.16 | 0.13 | 3.52 | 2.73 | 1.48 | 0.59 | 2.16 | 2.23 | 1.89 |
ROCE(%) | 6.16 | 6.58 | 3.9 | 4.03 | 4.46 | 3.83 | 4.7 | 5.15 | 5.03 |
Receivable days | 130.6 | 129.58 | 134.14 | 127.68 | 109.26 | 75.71 | 61.91 | 49.03 | 48.28 |
Inventory Days | 192.73 | 184.72 | 196.48 | 182.16 | 165.91 | 162.9 | 191.49 | 186.01 | 159.27 |
Payable days | 162.01 | 133.64 | 118.69 | 78.08 | 59.35 | 71.15 | 92.5 | 61.79 | 55.18 |
PER(x) | 0 | 0 | 163.48 | 224.81 | 338.96 | 513.1 | 145.12 | 208.56 | 300.68 |
Price/Book(x) | 0 | 0 | 3.87 | 6.07 | 4.97 | 3 | 3.11 | 4.58 | 5.64 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.34 | 1.27 | 4.69 | 6.81 | 4.39 | 2.15 | 2.28 | 2.81 | 2.81 |
EV/Core EBITDA(x) | 11.26 | 10.58 | 39.33 | 67.76 | 55.53 | 36.86 | 33.4 | 42.05 | 50.72 |
Net Sales Growth(%) | 0 | 12.17 | 1.24 | 14.62 | 29.97 | 29.63 | 5.87 | 18.53 | 22.79 |
EBIT Growth(%) | 0 | 10.3 | -20.63 | 12.87 | -3.04 | -11.89 | 37.96 | 22.93 | 1.59 |
PAT Growth(%) | 0 | 27.92 | 6779.85 | 17.2 | -44.81 | -59.98 | 274.11 | 5.3 | -12.95 |
EPS Growth(%) | 0 | 0 | 5448.63 | 17.2 | -44.81 | -59.98 | 274.14 | 5.3 | -12.95 |
Debt/Equity(x) | 4.82 | 2.06 | 0.69 | 0.28 | 0.26 | 0.31 | 0.54 | 0.59 | 0.6 |
Current Ratio(x) | 1.66 | 1.81 | 3.09 | 2.36 | 2.07 | 1.95 | 1.79 | 2.23 | 2.06 |
Quick Ratio(x) | 0.74 | 0.8 | 2.1 | 1.06 | 0.8 | 0.56 | 0.44 | 0.5 | 0.59 |
Interest Cover(x) | 1.21 | 1.15 | 1.3 | 1.86 | 1.66 | 1.35 | 1.58 | 1.76 | 1.5 |
Total Debt/Mcap(x) | 0 | 0 | 0.18 | 0.05 | 0.05 | 0.1 | 0.17 | 0.13 | 0.11 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 | 73.5 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 | 26.5 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 | 2.48 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About